Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Glatopa
Pharma
Novartis pushes past manufacturing blip with Copaxone copy
Novartis’ copycat arm, Sandoz, needed a win. And it got a key one Tuesday with the approval of generic 40-mg Copaxone.
Carly Helfand
Feb 13, 2018 9:32am
Novartis says generics sales will take Q2 hit, but it has a plan
May 31, 2017 10:41am
Novartis laggards Entresto, Alcon step up to help keep Q1 sales in line
Apr 25, 2017 11:21am
Pfizer plant slapped with warning letter for not learning from mistakes
Feb 28, 2017 12:27pm
Patient requests buoy oral meds from Biogen, Novartis in crowded MS market
Jan 25, 2017 6:54am
Teva asks FDA to raise the bar on new Copaxone copies
Oct 31, 2016 11:56am
